Thomas Frank E
Larimar Therapeutics, Inc. · Director
Thomas Frank E is listed in filings as Director at Larimar Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 20, 2026, including purchase activity. Recent filings connect the profile to Larimar Therapeutics, Inc. (LRMR) and Spero Therapeutics, Inc. (SPRO). The current snapshot covers public activity from May 14, 2025 to May 20, 2026. Reported amounts are shown as $183.7K to $35.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||